Epidemiology of Human Papillomavirus Infection and Cervical Cancer and Future Perspectives in Hong Kong, Singapore and Taiwan

Vaccine

Volumn 26, Issue SUPPL. 12, 2008, Pages

  Tay, Sun Kuie ^a   Ngan, Hextan Y S ^b   Chu, Tang Yuan ^c   Cheung, Annie N Y ^b   Hseon Tay, Eng ^d  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Department of Obstetrics and Gynaecology   (Taiwan)

^d KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

Asia Pacific; Cervical cancer; Epidemiology; Hong Kong; HPV; Singapore; Taiwan

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CHINESE; HONG KONG; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PAPANICOLAOU TEST; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SINGAPORE; SMOKING; TAIWAN; UTERINE CERVIX CANCER; VACCINATION; VIRUS CARCINOGENESIS; VIRUS ETIOLOGY; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; CARCINOMA IN SITU; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HONG KONG; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RISK FACTORS; SEXUAL BEHAVIOR; SINGAPORE; SMOKING; TAIWAN; UTERINE CERVICAL NEOPLASMS; VACCINATION; VAGINAL SMEARS; YOUNG ADULT;

EID: 50849096413     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.042     Document Type: Article

References (83)

1. Department of Health, The Government of the Hong Kong Special Administrative Region. Cervical Screening Programme. Available at: http://www.cervicalscreening.gov.hk/eindex.php (last accessed: April 2008).
2. The Health Promotion Board. CervicalScreen Singapore (CSS), cervical cancer screening programme. Available at: http://www.hpb.gov.sg/hpb/default.asp?pg_id=1741 (last accessed: April 2008).
3. Bureau of Health Promotion, Department of Health, ROC of Republic of Taiwan. Annual report 2006. http://crs.cph.ntu.edu.tw/crs_c/annual.html (last accessed: April 2008).
4. Chan M.K., Lau K.M., Tsui Y., Wong F.M., and Huang D.P. Human papillomavirus infection in Hong Kong Chinese women with normal and abnormal cervix-detection by polymerase chain reaction method on cervical scrapes. Gynaecol Oncol 60 2 (1996) 217-223
5. Chan P.K., Chang A.R., Tam W.H., and Cheung A.F. Prevalence and genotype distribution of cervical human papillomavirus infection: comparison between pregnant women and non-pregnant controls. J Med Virol 67 4 (2002) 583-588
6. Chan M.K., Mak K.H., Cheung N.L., Chan D.P., Lo K.K., and Cheung A.F. Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong. J Med Virol 68 (2002) 273-277
7. Chow V.T., Tham K.M., Lim-Tan S.K., Sng I.T., and Bernard H.U. Genital human papillomavirus infection among women from major ethnic groups in Singapore. Asia Oceania J Obstet Gynaecol 16 4 (1990) 373-377
8. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 3 (2007) 621-632
9. Lai C.H., Huang H.J., Hsueh S., Chao A., Lin C.T., Huang S.L., et al. Human papillomavirus genotype in cervical cancer: a population-based study. Int J Cancer 120 9 (2007) 1999-2006
10. Su T.H., Chang T.Y., Lee Y.J., Chen C.K., Liu H.F., Chu C.C., et al. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 28 6 (2007) 1237-1240
11. de Sanjose S., Diaz M., Castellsague X., Clifford G., Bruni L., Munoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7 7 (2007) 453-459
12. Lin H., Ma Y.Y., Moh J.S., Ou Y.C., Shen S.Y., and ChangChien C.C. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 101 1 (2006) 40-45
13. Lin H., Moh J.S., Ou Y.C., Shen S.Y., Tsai Y.M., ChangChien C.C., et al. A simple method for the detection and genotyping of high-risk human papillomavirus using seminested polymerase chain reaction and reverse hybridization. Gynecol Oncol 96 1 (2005) 84-91
14. Tham K.M., Chow V.T., Singh P., Tock E.P., Ching K.C., Lim-Tan S.K., et al. Diagnostic sensitivity of polymerase chain reaction and Southern blot hybridization for the detection of human papillomavirus DNA in biopsy specimens from cervical lesions. Am J Clin Pathol 95 5 (1991) 638-646
15. Lim-Tan S.K., Yoshikawa H., Sng I.T., de Villiers E.M., zur Hausen H., Ho T.H., et al. Human papillomavirus in dysplasia and carcinoma of the cervix in Singapore. Pathology 20 4 (1988) 317-319
16. Liaw K.L., Hsing A.W., Chen C.J., Schiffman M.H., Zhang T.Y., Hsieh C.Y., et al. Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer 62 (1995) 565-571
17. Liaw K.L., Hsing A.W., Schiffman M.H., You S.L., Zhang T., Burk R., et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer 73 (1997) 775-776
18. Chen C.A., Liu C.Y., Chou H.H., Chou C.Y., Ho C.M., Twu N.F., et al. The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group Study. Int J Gynecol Cancer 16 (2006) 1801-1808
19. Sun C.A., Liu J.F., Wu D.M., Nieh S., Yu C.P., and Chu T.Y. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 76 (2002) 41-47
20. Sun C.A., Lai H.C., Chang C.C., Neih S., Yu C.P., and Chu T.Y. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 83 (2001) 95-99
21. Chan P.K., Chang A.R., Cheung J.L., Chan D.P., Xu L.Y., Tang N.L., et al. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 185 (2002) 28-35
22. Lai H.C., Sun C.A., Yu M.H., Chen H.J., Liu H.S., and Chu T.Y. Favorable clinical outcome of cervical cancers infected with human papillomavirus type 58 and related types. Int J Cancer 84 (1999) 553-557
23. Chan P.K., Lam C.W., Cheung T.H., Li W.W., Lo K.W., Chan M.Y., et al. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst 94 (2002) 1249-1253
24. Clifford G.M., Rana R.K., Franceschi S., Smith J.S., Gough G., and Pimenta J.M. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1157-1164
25. Takami Y., Kondoh G., Saito J., Noda K., Sudiro T.M., Sjahrurachman A., et al. Cloning and characterization of human papillomavirus type 52 from cervical carcinoma in Indonesia. Int J Cancer 48 (1991) 516-522
26. Ho C.M., Chien T.Y., Huang S.H., Lee B.H., and Chang S.F. Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol 102 (2006) 54-60
27. Lai H.C., Peng M.Y., Nieh S., Yu C.P., Chang C.C., Lin Y.W., et al. Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis. Int J Gynecol Cancer 16 (2006) 730-735
28. Chan S.Y., Ho L., Ong C.K., Chow V., Drescher B., Durst M., et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 66 (1992) 2057-2066
29. Ho L., Chan S.Y., Burk R.D., Das B.C., Fujinaga K., Icenogle J.P., et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67 (1993) 6413-6423
30. Ong C.K., Chan S.Y., Campo M.S., Fujinaga K., Mavromara-Nazos P., Labropoulou V., et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67 (1993) 6424-6431
31. Calleja-Macias I.E., Villa L.L., Prado J.C., Kalantari M., Allan B., Williamson A.L., et al. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol 79 (2005) 13630-13640
32. Chan D.P., Cheung T.H., Tam A.O., Cheung J.L., Yim S.F., Lo K.W., et al. Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women. J Infect Dis 192 (2005) 1749-1756
33. Chan P.K., Cheung J.L., Cheung T.H., Lin C.K., Siu S.S., Yu M.M., et al. HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population. Gynecol Oncol 105 (2007) 736-741
34. Chan P.K., Cheung T.H., Lin C.K., Siu S.S., Yim S.F., Lo K.W., et al. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese. J Med Virol 79 (2007) 970-976
35. Lai H.C., Sytwu H.K., Sun C.A., Yu M.H., Yu C.P., Liu H.S., et al. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer 103 (2003) 221-225
36. Lai H.C., Chang C.C., Lin Y.W., Chen S.F., Yu M.H., Nieh S., et al. Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesis. Int J Cancer 113 (2005) 712-718
37. Lai H.C., Chu C.M., Lin Y.W., Chang C.C., Nieh S., Yu M.H., et al. Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer. Gynecol Oncol 96 (2005) 314-319
38. Lai H.C., Lin W.Y., Lin Y.W., Chang C.C., Yu M.H., Chen C.C., et al. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction. Gynecol Oncol 99 (2005) 113-118
39. Huang Y.K., Hsieh H.C., Sun J.A., Chao C.F., Huang R.L., Lai H.C., et al. Genetic polymorphisms of phase i and phase ii xenobiotic enzymes in human papillomavirus related lesion and cancer of the uterine cervix. Tzu Chi Med J 18 (2006) 267-274
40. Naucler P., Chen H.C., Persson K., You S.L., Hsieh C.Y., Sun C.A., et al. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol 88 (2007) 814-822
41. Sun C.A., Hsiung C.A., Lai C.H., Chen C.A., Chou C.Y., Ho C.M., et al. Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) Study. J Med Virol 77 (2005) 273-281
42. Hsieh C.Y., You S.L., Kao C.L., and Chen C.J. Reproductive and infectious risk factors for invasive cervical cancer in Taiwan. Anticancer Res 19 5C (1999) 4495-4500
43. Wang P.D., and Lin R.S. Risk factors for cervical intraepithelial neoplasia in Taiwan. Gynecol Oncol 62 (1996) 10-18
44. Cuzick J., De Stavola B., McCance D., Ho T.H., Tan G., Cheng H., et al. A case-control study of cervix cancer in Singapore. Br J Cancer 60 (1989) 238-243
45. Donnan S.P., Wong F.W., Ho S.C., Lau E.M., Takashi K., and Esteve J. Reproductive and sexual risk factors and human papilloma virus infection in cervical cancer among Hong Kong Chinese. Int J Epidemiol 18 1 (1989) 32-36
46. Chou P., Lai M.Y., and Chang H.J. Epidemiology of cervical cancer in the screened population in Taiwan, 1979-1984. Zhonghua Yi Xue Za Zhi (Taipei) 45 (1990) 209-221
47. Ho K.M. Sexually transmitted and lifestyle associated infections in adolescents. Bull Hong Kong Soc Infect Dis (2003) 7
48. Clores R.A. Teen survey on sexuality and relationship in Singapore (1999), Singapore Planned Parenthood Association
49. Sen P., Chio M.T.W., Tan H.H., and Chan R.K.W. Rising trends of STIs and HIV infection in Singapore-a review of epidemiology over the last 10 years (1994 to 2003). Ann Acad Med Singapore 35 (2006) 229-235
50. Tay S.K., and Singer A. The effects of oral contraceptive steroids, menopause and hormone replacement therapy on the cervical epithelium. In: Jordan J., Singer A., Jones H., and Shafi M. (Eds). The cervix (2006), Blackwell Scientific, London
51. Plummer M., Herrero R., Franceschi S., Meijer C.J., Snijders P.J., Bosch F.X., et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 14 9 (2003) 805-814
52. Wu M.T., Lee L.H., Ho C.K., Liu C.L., Wu T.N., Wu S.C., et al. Lifetime exposure to environmental tobacco smoke and cervical intraepithelial neoplasms among non smoking Taiwanese women. Arch Environ Health 58 6 (2003) 353-359
53. Tay S.K., and Tay K.J. Passive smoking is a risk factor for cervical neoplasia. Gynaecol Oncol 93 1 (2004) 116-120
54. Tsai H.T., Tsai Y.M., Yang S.F., Wu K.Y., Chuang H.Y., Wu T.N., et al. Lifetime cigarette smoke and second-hand smoke and cervical intraepithelial neoplasm-a community-based case-control study. Gynaecol Oncol 105 1 (2007) 181-188
55. Emmanuel S.C., Ho C.K., and Chen A.J. Cigarette smoking among school children in Singapore. Part I. Smoking prevalence. Singapore Med J 31 3 (1990) 211-216
56. Lai M.K., Ho D.S.Y., and Lam T.H. Trends of youth smoking in Hong Kong-year 1994, 1999 and 2003/2004. Proceedings of the 17th World Congress of Epidemiology. Bangkok, Thailand, August 21-25 (2005) 391
57. Wen C.P., Chien T., Tsai Y.Y., Liu W.Y., Tsai S.P., and Cheng T.Y. Are marketing campaigns in Taiwan by foreign tobacco companies targeting young smokers?. Tobacco Control 14 (2005) i38-i44
58. Chan R.K., and Tan H.H. Sexually transmitted infections in Singapore teenagers. Ann Acad Med Singapore 32 1 (2003) 25-28
59. Tan H.H., Chan R.K., and Goh C.L. Sexually transmitted diseases in the older population in Singapore. Ann Acad Med Singapore 31 4 (2002) 493-496
60. Koong S.L., Yen A.M., and Chen T.H. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan. J Med Screen 13 Suppl. 1 (2006) S44-S47
61. Fan Q., Tay S.K., and Shen K. Loop electrosurgical excision procedure: a valuable method for the treatment of cervical intraepithelial neoplasia. Zhonghua Fu Chan Ke Za Zhi 36 5 (2001) 271-274
62. Kwan TT, Chan KK, Yip AM, Tam KF, Cheung AN, Young PM, et al. Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative-quantitative study. Sex Transm Infect. 2008; in press.
63. Chan S.S., Cheung T.H., Lo W.K., and Chung T.K. Women's attitudes on human papillomavirus vaccination to their daughters. J Adolesc Health 41 2 (2007) 204-207
64. Cheung A.N., Chiu P.M., Tsun K.L., Khoo U.S., Leung B.S., and Ngan H.Y. Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology. J Clin Pathol 57 7 (2004) 721-727
65. Cheung A.N. Molecular targets in gynaecological cancers. Pathology 39 1 (2007) 26-45
66. Nieh S., Chen S.F., Chu T.Y., Lai H.C., Lin Y.S., Fu E., et al. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol 97 (2005) 35-40
67. Chen S.F., Yang S.F., Chu T.Y., Lai H.C., Lin Y.W., Bai C.Y., et al. Which test is a better strategy to determine the outcome of atypical glandular cell-categorized Pap smears? Immunocytochemical p16INK4A expression or human papillomavirus test-a retrospective cohort study. Gynecol Oncol 99 (2005) 578-584
68. Nieh S., Chen S.F., Chu T.Y., Lai H.C., and Fu E. Expression of p16 INK4A in papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix. Gynecol Oncol 91 (2003) 201-208
69. Liu S.S., Leung R.C., Chan K.Y., Chiu P.M., Cheung A.N., Tam K.F., et al. p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy. Clin Cancer Res 10 (2004) 3309-3316
70. Chung G.T., Huang D.P., Lo K.W., Chan M.K., and Wong F.W. Genetic lesion in the carcinogenesis of cervical cancer. Anticancer Res 12 (1992) 1485-1490
71. Wong Y.F., Chung T.K., Cheung T.H., Tam P.O., and Chang A.M. Frequent loss of heterozygosity of chromosome 3 short arm detected by PCR-based microsatellite polymorphisms in cervical squamous cell carcinoma. Cancer Lett 115 (1997) 161-164
72. Lai H.C., Lin Y.W., Chang C.C., Wang H.C., Chu T.W., Yu M.H., et al. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecol Oncol 104 (2007) 629-635
73. Ngan H.Y., Liu V.W., and Liu S.S. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer 80 (1999) 1828-1829
74. Chang C.L., Wang S.Y., Wu C.C., Su T.H., Wang K.L., Chen H.S., et al. Microsatellite alterations in exfoliated cervical epithelia deoxyribonucleic acid as a marker for high-grade dysplasia. Am J Obstet Gynecol 185 (2001) 108-115
75. Chu T.Y., Shen C.Y., Lee H.S., and Liu H.S. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer 24 (1999) 127-134
76. Cheung T.H., Lo K.W., Yim S.F., Poon C.S., Cheung A.Y., Chung T.K., et al. Clinicopathologic significance of loss of heterozygosity on chromosome 1 in cervical cancer. Gynecol Oncol 96 (2005) 510-515
77. Cheung T.H., Chung T.K., Poon C.S., Hampton G.M., Wang V.W., and Wong Y.F. Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma. Cancer 86 (1999) 1294-1298
78. Yu M.Y., Tong J.H., Chan P.K., Lee T.L., Chan M.W., Chan A.W., et al. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer 105 (2003) 204-209
79. Cheung T.H., Lo K.W., Yim S.F., Chan L.K., Heung M.S., Chan C.S., et al. Epigenetic and genetic alternation of PTEN in cervical neoplasm. Gynecol Oncol 93 (2004) 621-627
80. Chung T.K., Cheung T.H., Lo W.K., Yu M.Y., Hampton G.M., Wong H.K., et al. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia. Cancer Lett 154 (2000) 189-194
81. Yang H.J., Liu V.W., Wang Y., Chan K.Y., Tsang P.C., Khoo U.S., et al. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Gynecol Oncol 93 (2004) 435-440
82. Wong Y.F., Chung T.K., Cheung T.H., Nobori T., Yu A.L., Yu J., et al. Methylation of p16INK4A in primary gynecologic malignancy. Cancer Lett 136 (1999) 231-235
83. Seng T.J., Low J.S., Li H., Cui Y., Goh H.K., Wong M.L., et al. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 26 (2007) 934-944